Antagonism of the mu-delta opioid receptor heterodimer enhances opioid antinociception by activating Src and calcium/calmodulin-dependent protein kinase II signaling
Attila Keresztes(University of Arizona), John M. Streicher(University of Arizona), Natalie K. Barker(University of North Carolina at Chapel Hill), John P. Konhilas(University of Arizona), Keith M. Olson(University of Michigan), Ryan Hecksel(University of Arizona), Paul Nguyen(University of Arizona), Victor J. Hruby(University of Arizona), Marissa A. Lopez‐Pier(University of Arizona), Zekun Liu(University of Arizona), Paul R. Langlais(University of Arizona)
Cited by 28
Related Papers
Emerging approaches in the molecular design of receptor-selective peptide ligands: conformational, topographical and dynamic considerations
|Biochemical Journal|1990|520
Diverse Actions of Ovarian Steroids in the Serotonin Neural System
|Frontiers in Neuroendocrinology|2002|485
Exercise Can Prevent and Reverse the Severity of Hypertrophic Cardiomyopathy
|Circulation Research|2006|189
Development of Functionally Selective, Small Molecule Agonists at Kappa Opioid Receptors
|Journal of Biological Chemistry|2013|148